Novel antisense drug shows promise in slowing fatty liver disease

(University of California - San Diego) A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news